The federal Medicare program for the elderly and disabled will cover two new drugs that can cure hepatitis C, a liver disease that can cause cancer and lead to death. The drugs are very expensive, but they cure hepatitis C in most cases. The government and insurers are concerned about these costs; three million Americans have hepatitis C, most of whom don't know they have it.
To Pay For Hepatitis C Drugs, Medicare Might Face A Steep Bill
By Melissa Block • May 16, 2014
Originally published on May 16, 2014 6:00 pm